Skip to main content
  • Medicaid Provider Alert: Provider revalidation has begun and those not completing the process risk disenrollment.  Check your account now to learn when your revalidation is due. More information here.

Drugs and Therapeutics (D&T) Committee Meeting Results for: June 10, 2015

Drug Name Review Type Committee Recommendation Prior Approval Status � Final Determination
Afrezza New Drug Initial Review Require Prior Approval Prior Approval Required
Bunavail New Drug Initial Review Require Prior Approval Prior Approval Required
Qudexy XR New Drug Initial Review Require Prior Approval Prior Approval Required
Toujeo New Drug Initial Review Require Prior Approval Prior Approval Required
Viekera Pak New Drug Appeal Require Prior Approval Prior Approval Required